Arthritis, Psoriatic: all 594 studies
Page 5 of 6. Open to participants first (132), then studies with results posted, then the rest; newest registration first within each.
- Assessment of Treatment Safety and Quality of Life in Patients Receiving Etanercept Biosimilar for Autoimmune ArthritisCompletedNCT04582084
- Comparison of Hand Functions and Wrist Proprioception in Patients With and Without Psoriatic ArthritisCompletedNCT04553302
- A Study of Oral Upadacitinib (RINVOQ) Tablets to Assess Adverse Events and Change in Disease Symptoms in Korean Participants With Moderate to Severe Active Rheumatoid Arthritis, Atopic Dermatitis, Ankylosing Spondylitis or Psoriatic ArthritisCompletedNCT04541810
- The Effect of Psoriatic Arthritis on the Functions of the HandCompletedNCT04540809
- Danish Population-based Assessment of Psoriasis and Psoriatic Arthritis (DANPAPP)Status unknownNCT04515732Phase 4
- Axial Involvement in Psoriatic Arthritis CohortStatus unknownNCT04434885
- Study to Assess the Safety and Change in Disease Symptoms of Risankizumab (Skyrizi) in Adult Participants With Moderate to Severe Plaque Psoriasis and Psoriatic ArthritisCompletedNCT04433442
- Tapering of Biologics in Inflammatory Arthritis Patients in RemissionActive, not recruitingNCT04429776Not applicable
- Impact of Barriers and Facilitators to Physical Activity in Patients With Inflammatory ArthritisStatus unknownNCT04426747
- SystemIc iNflammation and Microvascular diSease PreventIon in psoRiatic diseasEWithdrawnNCT04417114Phase 4
- Survey of Cannabis Use in Patients With Chronic Inflammatory ArthritisCompletedNCT04402554
- IMPACT: IMPact of Antimalarials on Covid-19 Infections in RAPPORTCompletedNCT04347798
- Association Between Long-term Hydroxychloroquine Treatment and Outcome of a History of Symptoms Suggestive of COVID-19 Infection During the Epidemic Period in France in Patients With Autoimmune DiseaseCompletedNCT04345159
- Enhanced Clinics for Patients Diagnosed With Ankylosing Spondylitis and Psoriatic ArthritisWithdrawnNCT04341233
- COVID-19 Infection in Vulnerable Patients With Inflammatory Rheumatic DiseasesTerminatedNCT04335747
- Evaluation of the Role of Inflammatory and Structural Ultrasound Abnormalities by Explaining the Perspective of Patients With Psoriatic ArthritisStatus unknownNCT04325724Not applicable
- Information and Acceptability of BiosimilarsStatus unknownNCT04321291Not applicable
- Comparison of the Effectiveness of Functional Training Versus Resistance Exercises in Patients With Psoriatic ArthritisCompletedNCT04304326Not applicable
- Evaluating of New Screening Tool for Arthritis* in PsoriasisCompletedNCT04277832
- TNF and IL23 Blocking Agents Gene Expression Ratios in the Psoriatic Arthritis Synovium_(TIGERS) StudyCompletedNCT04261010Not applicable
- The Epidemiology, Management, and the Associated Burden of Related Conditions in Alopecia AreataCompletedNCT04239521
- Effectiveness of Interdisciplinary Care Compared to Usual Care in Patients With Immune-Mediated Inflammatory DiseasesActive, not recruitingNCT04200690Not applicable
- Frequency of Elevated Fecal Calprotectin Levels in Psoriatic Arthritis.CompletedNCT04190108
- A Phase 4 Clinical Study of BrodalumabCompletedNCT04183881Phase 4
- PsA T2T Statin Trial on Carotid and Coronary AtherosclerosisWithdrawnNCT04176978Not applicable
- Anti-Carbamylated Protein Antibodies in Psoriatic ArthritisCompletedNCT04173039Not applicable
- Comparative Study to Evaluate the Pharmacokinetics of BAT2506 vs Simponi® in Healthy SubjectsCompletedNCT04152759Phase 1
- Impact of Decision-Framing in PsoriasisCompletedNCT04136314Not applicable
- Low Dose Naltrexone for Chronic Pain in Osteoarthritis and Inflammatory ArthritisWithdrawnNCT04115020Phase 2
- Psoriatic Arthritis D2P ScreeningActive, not recruitingNCT04110522Not applicable
- Abatacept Bone Effects in Psoriatic Arthritis With Bone BiomarkerStatus unknownNCT04106804Phase 4
- Validation of the PsASon ULtrasound Scores in Patients With Psoriatic Arthritis Undergoing TReatment With ApremilastWithdrawnNCT04102449Phase 4
- A Real-world Study of Imraldi® UseCompletedNCT04089514
- Yoga-mindfulness for Pain Management in Inflammatory ArthritisSuspendedNCT04065958Not applicable
- Tofacitinib for Reduction of Spinal Inflammation in Patients With Psoriatic ArthritiS PresenTing With Axial InvOlvementStatus unknownNCT04062695Phase 2
- Comparison of PK and Tolerability of MSB11022 Administered by AI or PFSCompletedNCT04018599Phase 1
- A Study to Assess the Long-term Safety, Tolerability, and Efficacy of Bimekizumab in the Treatment of Subjects With Active Psoriatic ArthritisCompletedNCT04009499Phase 3
- Survivorship and Patient Outcomes of Primary Total Hip Arthroplasty With the Ovation Hip SystemStatus unknownNCT03986918
- Ultrasound Enthesitis Response in Psoriatic ArthritisCompletedNCT03955861
- CD73+ Th1.17 in Rheumatoid Arthritis and Psoriatic ArthritisCompletedNCT03953378
- WORKWELL: Testing Work Advice for People With ArthritisCompletedNCT03942783Not applicable
- Metabolic Syndrome in Psoriasis and Psoriatic Arthritis and Correlation With Serum Omentin and Visfatin LevelsCompletedNCT03932110Not applicable
- PatientSpot Formerly Known as ArthritisPowerStatus unknownNCT03840928
- A Study to Evaluate the Use of Apremilast in Patients With Psoriatic Arthritis, Naïve to Biological TreatmentCompletedNCT03828045
- Changes in Body Composition Under Ustekinumab in PsATerminatedNCT03823924
- Discovery of Arthritis in Psoriasis Patients for Early Rheumatological ReferralCompletedNCT03816917
- A Study of Guselkumab in Participants With Active Psoriatic Arthritis and an Inadequate Response to Anti-Tumor Necrosis Factor Alpha (Anti-TNF Alpha) TherapyCompletedNCT03796858Phase 3
- Apremilast in Psoriatic Arthritis in Real-life Clinical Practice in GreeceStatus unknownNCT03780504
- Psoriatic Arthritis and Psoriasis Treatment Decision AidCompletedNCT03737045Not applicable
- Safety and Efficacy of Tofacitinib vs Methotrexate in the Treatment of Psoriatic ArthritisCompletedNCT03736161Phase 3
- Central Pain Mechanisms in Patients With Hand-Osteoarthritis, Psoriatic Arthritis and Healthy ControlsSuspendedNCT03703934
- CBD Treatment in Hand Osteoarthritis and Psoriatic Arthritis.CompletedNCT03693833Phase 2
- One-year Persistence to Treatment of Participants Receiving Flixabi or Imraldi: a French Cohort StudyCompletedNCT03662919
- Post Market Clinical Follow-up (PMCF) Study of the A.L.P.S. Proximal Humerus Plating SystemActive, not recruitingNCT03626038Not applicable
- Impact of Nurse-led Programme With Carotid Ultrasound on Addressing Cardiovascular Risk in Patients With ArthritisWithdrawnNCT03625089Not applicable
- PsA Secukinumab XCT Structural Progression StudyCompletedNCT03623867Phase 4
- Treatment Goals in Psoriatic ArthritisCompletedNCT03620188
- Study to Evaluate the Real-World Effectiveness, Safety and Tolerability of Treatment With Apremilast in Psoriatic Arthritis Patients Followed in Canadian Routine Care (APPRAISE)CompletedNCT03608657
- Clinical Study of Efficacy and Safety of BCD-085 (Monoclonal Anti-IL-17 Antibody) in Psoriatic ArthritisCompletedNCT03598751Phase 3
- Mechanism of Action of Ustekinumab in Psoriatic ArthritisStatus unknownNCT03565042
- Early Biomarkers for ARthritic PAIN to Guide Improved Treatments for ArthritisStatus unknownNCT03533569
- Predicting Hospitalized Infection in Patients With Chronic Inflammatory Arthritis Treated With Biological DrugsCompletedNCT03496831
- PROM Collected Via a Smartphone App Versus a Touch Screen Solution Among Patients With Inflammatory ArthritisCompletedNCT03486613Not applicable
- Investigating the Utilisation and Effectiveness of Originator and Biosimilar Anti-TNF AgentsStatus unknownNCT03470688
- Chronic Inflammatory Disease, Lifestyle and Risk of DiseaseStatus unknownNCT03456206
- Identification of New Prognostic Markers in Psoriatic ArthritisCompletedNCT03455166Not applicable
- Research Study on the Immunosuppressive Effects of a Cell Therapy Product on PBMC Isolated From Blood of Patients With Inflammatory Rheumatic DiseasesTerminatedNCT03454932
- Fertility Study of Women With Chronic Inflammatory RheumatismStatus unknownNCT03452735
- Clinical Impact of Acthar in the Psoriatic Arthritis Patient (CLIPS)CompletedNCT03419650Phase 4
- Safety and Effectiveness of Abatacept in Psoriatic Arthritis ParticipantsCompletedNCT03419143
- Mindfulness Based Stress Reduction in Rheumatic DiseasesTerminatedNCT03411057
- Patterns After Administration of MCFAs in Psoriasis and Psoriatic ArthritisCompletedNCT03409211Not applicable
- A Study to Investigate BMS-986165 and Methotrexate in Healthy Male PatientsCompletedNCT03402087Phase 1
- Immune Metabolic Associations in Psoriatic ArthritisCompletedNCT03399708
- Disparity Between Ultrasound- and Clinical Findings in Psoriatic Arthritis in RemissionCompletedNCT03396679
- Recirculating Memory T Cells in the Pathogenesis of Psoriatic Arthritis and Cutaneous PsoriasisCompletedNCT03374527
- A Study to Characterize Profile of Participant With Psoriatic Arthritis Depending on Whether Their Disease is Managed by a Dermatologist or by a Rheumatologist, and Starting UstekinumabCompletedNCT03336281
- Ultrasound in Psoriatic Arthritis TreatmentStatus unknownNCT03330769
- An Open-label, Long-term Extension Study With Filgotinib in Active Psoriatic Arthritis.TerminatedNCT03320876Phase 2
- Post-Marketing Surveillance Study of OTEZLACompletedNCT03284879
- The Effect of BMS-986165 Combined With an Oral Contraceptive (Ethinyl Estradiol/Norethindrone) in Healthy Female PatientsCompletedNCT03262727Phase 1
- A Study to Evaluate BMS-986165 Tablet Formulation Relative to BMS-986165 Capsule Formulation and the Effect of a High-Fat/ High-Calorie Meal and Increased Gastric pH on the BMS-986165 Tablet FormulationCompletedNCT03254784Phase 1
- Lessening the Impact of Fatigue in Inflammatory Rheumatic DiseasesCompletedNCT03248518Not applicable
- Impact of AbbVie Care Patient Support Program on Clinical, Health Economic and Patient Reported Outcomes, in Crohn's Disease, Ulcerative Colitis, Rheumatoid Arthritis, Psoriatic Arthritis, Psoriasis and Axial Spondyloarthritis, in the Portuguese National Health ServiceCompletedNCT03223012
- Assessment of the Clinical and Ultrasound Response to Apremilast by Clinical Evaluation and by a Joint-periarticular-nail Ultrasound Index in Patients With Active Psoriatic ArthritisStatus unknownNCT03191539Phase 3
- Chronic Inflammatory Disease, Lifestyle and Treatment ResponseCompletedNCT03173144
- Pharmacist CVD Intervention for Patients With Inflammatory ArthritisStatus unknownNCT03152396Not applicable
- Impact of Concomitant MTX on Efficacy, Safety and Adherence of Ustekinumab-treatment in Patients With Active PsACompletedNCT03148860Phase 3
- The DIET Trial - Dietetic Intervention in Psoriatic ArthritisCompletedNCT03142503Not applicable
- Remission and Flare in Psoriatic Arthritis: a Prospective 6-month Study With a Double Perspective.CompletedNCT03119805
- Study of Apremilast Use in Patients With Psoriatic Arthritic in Practice ConditionsCompletedNCT03106051
- A Study to Assess Efficacy and Safety of Filgotinib in Active Psoriatic ArthritisCompletedNCT03101670Phase 2
- A Study of the Real-life Management of Psoriatic Arthritis Patients Treated With Otezla® (Apremilast) in BelgiumCompletedNCT03096990
- The Norwegian Drug Monitoring StudyCompletedNCT03074656Not applicable
- Efficacy and Safety of Fecal Microbiota Transplantation in Peripheral Psoriatic ArthritisCompletedNCT03058900Not applicable
- DC-STAMP: Regulators of Osteoclastogenesis and Response Marker in PsACompletedNCT03011242
- Tracking Biologics Along the Silk RoadCompletedNCT03006198
- Interval Training Study in Psoriatic ArthritisCompletedNCT02995460Not applicable
- A Study to Assess Retention Rate, Persistence and Adherence in Population of Spondylarthritis (Ankylosing Spondylitis and Psoriatic Arthritis) Patients Treated With Adalimumab in Routine Clinical Settings in Russian FederationCompletedNCT02988674
- Comparation of Ultrasonic Imaging of Enthesopathy in Patients With Psoriatic Arthritis and PsoriasisStatus unknownNCT02962271